Qualigen therapeutics, inc. to present at the ld micro invitational xi conference

Carlsbad, calif., june 02, 2021 (globe newswire) -- qualigen therapeutics, inc. (nasdaq: qlgn), a biotechnology company focused on developing novel therapeutics for the treatment of cancer and viral diseases, announced today that its ceo and chairman michael poirier will present and participate at the virtual ld micro invitational xi conference, hosted by sequire virtual events, taking place on june 8-10, 2021.
QLGN Ratings Summary
QLGN Quant Ranking